Home Other Building Blocks Benzofuroxan

Benzofuroxan

CAS No.:
480-96-6
Catalog Number:
AG0034HY
Molecular Formula:
C6H4N2O2
Molecular Weight:
136.1082
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5g
97%
In Stock USA
United States
$13
- +
25g
97%
In Stock USA
United States
$38
- +
100g
97%
In Stock USA
United States
$100
- +
500g
97%
In Stock USA
United States
$300
- +
Product Description
Catalog Number:
AG0034HY
Chemical Name:
Benzofuroxan
CAS Number:
480-96-6
Molecular Formula:
C6H4N2O2
Molecular Weight:
136.1082
MDL Number:
MFCD00005807
IUPAC Name:
3-oxido-2,1,3-benzoxadiazol-3-ium
InChI:
InChI=1S/C6H4N2O2/c9-8-6-4-2-1-3-5(6)7-10-8/h1-4H
InChI Key:
OKEAMBAZBICIFP-UHFFFAOYSA-N
SMILES:
[O-][n+]1onc2c1cccc2
EC Number:
207-559-1
UNII:
34FFO6Y520
NSC Number:
19930
Properties
Complexity:
131  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
136.027g/mol
Formal Charge:
0
Heavy Atom Count:
10  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
136.11g/mol
Monoisotopic Mass:
136.027g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
51.5A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.4  
Literature
Title Journal
Identification of thioredoxin glutathione reductase inhibitors that kill cestode and trematode parasites. PloS one 20120101
Synthesis and evaluation of a series of 2-substituted-5-thiopropylpiperazine (piperidine)-1,3,4-oxadiazoles derivatives as atypical antipsychotics. PloS one 20120101
Novel benzofuroxan derivatives against multidrug-resistant Staphylococcus aureus strains: design using Topliss' decision tree, synthesis and biological assay. Bioorganic & medicinal chemistry 20110815
Synthesis of quinoxaline 1,4-di-N-oxide analogues and crystal structure of 2-carbomethoxy-3-hydroxyquinoxaline-di-N-oxide. Molecules (Basel, Switzerland) 20110812
The stepwise Diels-Alder reaction of 4-nitrobenzodifuroxan with Danishefsky's diene. Chemistry (Weinheim an der Bergstrasse, Germany) 20110627
A small-molecule inhibitor of MDMX activates p53 and induces apoptosis. Molecular cancer therapeutics 20110101
Structural relationships in the solid state of the anti-chagas agent (E)-phenylethenylbenzofuroxan. Molecular diversity 20101101
o-Benzoquinone dioxime. Acta crystallographica. Section E, Structure reports online 20101101
Mode of action of nifurtimox and N-oxide-containing heterocycles against Trypanosoma cruzi: is oxidative stress involved? Biochemical pharmacology 20100615
Synthesis and pharmacological characterization of a novel nitric oxide-releasing diclofenac derivative containing a benzofuroxan moiety. European journal of medicinal chemistry 20100601
Synthesis and anticonvulsant activity of a new series of 1,4-dihydropyridine derivatives. Indian journal of pharmaceutical sciences 20100101
Anti-trypanosomatid benzofuroxans and deoxygenated analogues: synthesis using polymer-supported triphenylphosphine, biological evaluation and mechanism of action studies. European journal of medicinal chemistry 20091201
Cytotoxic, mutagenic and genotoxic effects of new anti-T. cruzi 5-phenylethenylbenzofuroxans. Contribution of phase I metabolites on the mutagenicity induction. Toxicology letters 20091028
Design, synthesis, antimicrobial activity and molecular modeling studies of novel benzofuroxan derivatives against Staphylococcus aureus. Bioorganic & medicinal chemistry 20090415
In vivo studies of 5-arylethenylbenzofuroxans in acute murine models of Chagas' disease. European journal of medicinal chemistry 20081001
New trypanocidal hybrid compounds from the association of hydrazone moieties and benzofuroxan heterocycle. Bioorganic & medicinal chemistry 20080715
Development of a HPLC method for the determination of antichagasic phenylethenylbenzofuroxans and its major synthetic secondary products in the chemical production processes. Journal of pharmaceutical and biomedical analysis 20080512
Substitutions of fluorine atoms and phenoxy groups in the synthesis of quinoxaline 1,4-di-N-oxide derivatives. Molecules (Basel, Switzerland) 20080118
In vivo anti-Chagas vinylthio-, vinylsulfinyl-, and vinylsulfonylbenzofuroxan derivatives. Journal of medicinal chemistry 20071129
Synthesis of neutral spin-delocalized electron acceptors for multifunctional materials. Organic letters 20071108
Evidence for the intermediacy of Wheland-Meisenheimer complexes in SEAr reactions of aminothiazoles with 4,6-dinitrobenzofuroxan. Chemistry (Weinheim an der Bergstrasse, Germany) 20070101
New potent 5-substituted benzofuroxans as inhibitors of Trypanosoma cruzi growth: quantitative structure-activity relationship studies. Bioorganic & medicinal chemistry 20051201
Pharmacological properties of furoxans and benzofuroxans: recent developments. Mini reviews in medicinal chemistry 20050101
Identification of 2,3-diaminophenazine and of o-benzoquinone dioxime as the major in vitro metabolites of benzofuroxan. Xenobiotica; the fate of foreign compounds in biological systems 20040401
Nonselective inhibition of monoamine oxidases A and B by activators of soluble guanylate cyclase. Biochemistry. Biokhimiia 20030901
Sigma-complex formation and oxidative nucleophilic aromatic substitution in 4-nitro-2,1,3-benzoxadiazoles. Organic & biomolecular chemistry 20030621
Nitroanilines are the reduction products of benzofuroxan system by oxyhemoglobin (HbO2 2+). Farmaco (Societa chimica italiana : 1989) 20011001
Toward an understanding of the furoxan-dinitrosoethylene equilibrium. Journal of the American Chemical Society 20010801
[Formations and reactions of aromatic furazan compounds]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20010601
Properties